Risks

High net debt to EBITDA at 6.1x and interest coverage near 2.0x leave CMSA more exposed than stronger peers if refinancing costs rise or earnings soften over 1–3 years.

Current and quick ratios below 1.0 indicate tighter liquidity than peers, increasing sensitivity to working-capital shocks and limiting flexibility versus better-capitalized competitors.

Days sales outstanding near 42 and inventory days above 112 suggest slower cash collection and stock conversion than leaner peers, which can pressure margins and funding needs.

Days payables outstanding near 167 supports cash flow but also signals reliance on supplier financing, a riskier structure than peers with stronger self-funding capacity.

Opportunities

Negative cash conversion cycle indicates CMSA converts working capital into cash faster than many peers, supporting liquidity and reducing external funding dependence.

Extended payables terms can preserve cash generation relative to peers, creating a modest buffer if demand remains stable and supplier relationships hold.

If operating performance improves, the high leverage can amplify equity upside more than for lower-levered peers, though this remains contingent on sustained earnings recovery.

Overall Score

CMSA’s forward positioning is constrained by elevated leverage and weaker liquidity versus peers, while efficient working-capital conversion and supplier financing provide only a modest offset.